Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
119 hedge funds and large institutions have $203M invested in Arena Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 11 closing their positions.
73% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 11
67% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $887K
30% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 30
7% more funds holding
Funds holding: 111 → 119 (+8)
10% less capital invested
Capital invested by funds: $225M → $203M (-$22.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$18.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.24M |
| 3 |
Renaissance Technologies
New York
|
+$2.1M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.09M |
| 5 |
GC
Globeflex Capital
San Diego,
California
|
+$1.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$18.4M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.49M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.07M |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$455K |
| 5 |
AIG
American International Group
New York
|
-$379K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HNB
126
Huntington National Bank
Columbus,
Ohio
| – | -$11K | -259 | Closed |
|
127
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$3K | -139 | Closed |
|
|
MFS
128
MSI Financial Services
Springfield,
Massachusetts
| – | -$1.32K | -74 | -74% |
|
|
FCCM
129
First City Capital Management
Savannah,
Georgia
| – | -$197 | -10 | Closed |
|
ARNA Hedge Fund Activity: Q2 2016 in Review
119 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2016, worth a combined $203M — down 9.8% from $225M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ARNA positions and 11 closed out — a net gain of 8 holders — while 39 added to existing stakes and 30 trimmed.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $18.8M. The largest seller was RA Capital Management, exiting entirely with an estimated $18.4M sold.
- 119 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2016, up from 111 in Q1 2016.
- Funds reported $203M of Arena Pharmaceuticals Inc stock for Q2 2016, down 9.8% quarter-over-quarter.
- 19 funds opened new Arena Pharmaceuticals Inc positions in Q2 2016 and 11 closed out, a net change of +8 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q2 2016 was Camber Capital Management, an estimated $18.8M added.
- The largest Arena Pharmaceuticals Inc seller in Q2 2016 was RA Capital Management, an estimated $18.4M sold.
Based on aggregated 13F filings for Q2 2016.